Ali Akbar Velayati1, Parissa Farnia1, Mehdi Mirsaeidi2. 1. Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Division of Pulmonary and Critical Care, University of Illinois at Chicago, Chicago, IL. Electronic address: mmirsae@uic.edu.
Authors: Ali Akbar Velayati; Parissa Farnia; Mohammad Reza Masjedi; Gennady Konstantinovich Zhavnerko; Jalaledin Ghanavi; Nikolai Nikolaevich Poleschuyk Journal: J Infect Dev Ctries Date: 2012-01-12 Impact factor: 0.968
Authors: A A Velayati; P Farnia; M R Masjedi; T A Ibrahim; P Tabarsi; R Z Haroun; H O Kuan; J Ghanavi; P Farnia; M Varahram Journal: Eur Respir J Date: 2009-11 Impact factor: 16.671
Authors: Ali Akbar Velayati; Parissa Farnia; Mohadese Mozafari; Donya Malekshahian; Amir Masoud Farahbod; Shima Seif; Snaz Rahideh; Mehdi Mirsaeidi Journal: Chest Date: 2015-04 Impact factor: 9.410
Authors: Mehdi S Mirsaeidi; Payam Tabarsi; Parissa Farnia; Golnaz Ebrahimi; Matthew W Morris; Mohammad R Masjedi; Ali A Velayati; Davood Mansouri Journal: Saudi Med J Date: 2007-04 Impact factor: 1.484